Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Charles Quick

Concepts (394)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
18
2021
145
4.690
 Why?
Carcinoma in Situ
7
2022
74
2.050
 Why?
Uterine Neoplasms
10
2023
65
2.040
 Why?
Vulvar Neoplasms
5
2022
54
1.980
 Why?
Carcinoma, Endometrioid
6
2021
41
1.690
 Why?
PAX2 Transcription Factor
7
2015
22
1.510
 Why?
Carcinoma, Squamous Cell
8
2019
385
1.470
 Why?
Adenocarcinoma
9
2019
428
1.440
 Why?
Endometrial Hyperplasia
4
2019
14
1.190
 Why?
Stromal Cells
2
2016
79
1.070
 Why?
Uterine Cervical Neoplasms
6
2021
276
1.050
 Why?
Ovarian Neoplasms
9
2018
474
1.030
 Why?
Sarcoma, Alveolar Soft Part
1
2023
1
0.940
 Why?
Myometrium
2
2013
15
0.890
 Why?
Endometrium
6
2023
43
0.870
 Why?
Female
63
2024
28457
0.850
 Why?
Adenocarcinoma, Clear Cell
6
2019
37
0.810
 Why?
Precancerous Conditions
3
2019
93
0.780
 Why?
Cystadenocarcinoma, Serous
4
2013
74
0.720
 Why?
Aged, 80 and over
19
2021
3430
0.700
 Why?
Cannabidiol
4
2020
35
0.690
 Why?
Tumor Suppressor Protein p53
2
2017
251
0.670
 Why?
Peripheral Nerves
2
2015
51
0.650
 Why?
Middle Aged
33
2021
13076
0.610
 Why?
Humans
65
2023
54304
0.610
 Why?
Placenta
6
2021
136
0.600
 Why?
Epithelial-Mesenchymal Transition
2
2016
53
0.590
 Why?
Cervix Uteri
2
2017
53
0.590
 Why?
Aged
28
2021
10054
0.580
 Why?
Adenosarcoma
1
2016
3
0.580
 Why?
Immunohistochemistry
15
2020
1090
0.570
 Why?
Polyps
1
2016
19
0.560
 Why?
Adult
30
2021
14189
0.550
 Why?
Uterine Cervical Dysplasia
1
2016
51
0.550
 Why?
Mutation
8
2021
1504
0.540
 Why?
Tumor Microenvironment
4
2021
210
0.530
 Why?
Fallopian Tubes
2
2012
26
0.520
 Why?
Fibroma
1
2015
41
0.520
 Why?
Lymphatic Metastasis
6
2019
256
0.520
 Why?
Plant Extracts
4
2020
192
0.500
 Why?
Neoplasm Staging
8
2019
805
0.470
 Why?
Neoplasm Invasiveness
6
2019
294
0.460
 Why?
Prognosis
10
2021
2126
0.420
 Why?
Pelvic Neoplasms
1
2011
20
0.410
 Why?
Uterus
3
2023
100
0.400
 Why?
Lymphocytes, Tumor-Infiltrating
3
2021
74
0.400
 Why?
Ejaculatory Ducts
1
2010
3
0.380
 Why?
Seminal Vesicles
1
2010
12
0.380
 Why?
Neoplasm Recurrence, Local
4
2015
645
0.370
 Why?
Cannabis
4
2020
149
0.370
 Why?
Spectrum Analysis, Raman
2
2021
68
0.360
 Why?
Prostate
1
2010
123
0.350
 Why?
Bromcresol Purple
1
2009
4
0.350
 Why?
Electrophoresis, Capillary
1
2009
16
0.340
 Why?
Serum Albumin
1
2009
62
0.340
 Why?
Human papillomavirus 16
2
2021
48
0.330
 Why?
beta Catenin
2
2021
102
0.320
 Why?
Methionine
2
2020
146
0.320
 Why?
Disease Progression
4
2020
915
0.320
 Why?
Papillomavirus Infections
2
2022
163
0.310
 Why?
Papillomavirus Vaccines
2
2021
68
0.310
 Why?
Genital Neoplasms, Female
2
2018
41
0.310
 Why?
Diabetes Mellitus
2
2023
309
0.300
 Why?
Anus Neoplasms
2
2018
33
0.300
 Why?
Metaplasia
2
2019
20
0.300
 Why?
Cell Proliferation
4
2021
1097
0.290
 Why?
Antigens, CD
2
2019
242
0.290
 Why?
Diagnosis, Differential
8
2020
1143
0.280
 Why?
Colitis
2
2020
53
0.280
 Why?
Prostatic Neoplasms
1
2010
421
0.270
 Why?
Polyethylene Glycols
2
2017
107
0.270
 Why?
Neoplasm Grading
5
2021
131
0.270
 Why?
Mice
14
2024
6428
0.270
 Why?
Melanoma
2
2020
313
0.270
 Why?
Hypertension
2
2021
564
0.260
 Why?
Chi-Square Distribution
2
2016
318
0.260
 Why?
Gold
2
2017
164
0.260
 Why?
Proteomics
3
2017
343
0.250
 Why?
Aspartic Acid Endopeptidases
2
2015
17
0.250
 Why?
Nanoparticles
2
2017
173
0.250
 Why?
Racemases and Epimerases
2
2015
15
0.250
 Why?
Retrospective Studies
11
2020
6462
0.240
 Why?
Basic Helix-Loop-Helix Transcription Factors
1
2024
44
0.230
 Why?
Homeodomain Proteins
1
2024
82
0.230
 Why?
Head and Neck Neoplasms
2
2019
336
0.230
 Why?
Chlamydia muridarum
1
2024
53
0.230
 Why?
Kidney Neoplasms
2
2018
197
0.230
 Why?
Endometriosis
1
2023
16
0.230
 Why?
Lung Neoplasms
2
2019
643
0.230
 Why?
Gynecology
2
2020
50
0.220
 Why?
Adenocarcinoma, Sebaceous
1
2022
6
0.220
 Why?
Sebaceous Gland Neoplasms
1
2022
15
0.220
 Why?
Observer Variation
3
2017
139
0.210
 Why?
Young Adult
6
2020
4313
0.210
 Why?
Chlamydia Infections
1
2024
119
0.210
 Why?
CD4-Positive T-Lymphocytes
1
2024
181
0.210
 Why?
Fallopian Tube Neoplasms
2
2012
19
0.210
 Why?
Gestational Trophoblastic Disease
2
2012
2
0.210
 Why?
Animals
15
2024
14402
0.210
 Why?
Immunotherapy
2
2021
264
0.210
 Why?
CTLA-4 Antigen
1
2021
29
0.200
 Why?
Oncogene Fusion
1
2021
4
0.200
 Why?
Fetal Membranes, Premature Rupture
1
2021
23
0.200
 Why?
Genotype
2
2021
600
0.200
 Why?
PTEN Phosphohydrolase
3
2020
61
0.200
 Why?
Estrogens
2
2023
244
0.200
 Why?
Leiomyosarcoma
1
2021
25
0.200
 Why?
Diabetes, Gestational
1
2021
54
0.190
 Why?
Transcription Factors
3
2020
622
0.190
 Why?
Carcinosarcoma
2
2017
18
0.190
 Why?
Cancer Vaccines
1
2021
103
0.190
 Why?
Infant, Small for Gestational Age
1
2020
34
0.190
 Why?
Neoplasms, Experimental
1
2020
115
0.180
 Why?
Carcinoma, Papillary
1
2020
65
0.180
 Why?
Carcinoma, Transitional Cell
1
2020
54
0.180
 Why?
Pregnancy in Diabetics
1
2020
25
0.180
 Why?
Carcinoma, Signet Ring Cell
1
2019
14
0.180
 Why?
Pregnancy Complications, Neoplastic
1
2019
23
0.180
 Why?
Carcinoma, Lewis Lung
1
2019
11
0.180
 Why?
Placenta Diseases
1
2019
14
0.180
 Why?
DNA Mutational Analysis
2
2018
217
0.180
 Why?
Colonic Neoplasms
1
2021
164
0.180
 Why?
Radiotherapy
1
2020
137
0.180
 Why?
Hepatic Veno-Occlusive Disease
1
2019
10
0.180
 Why?
Carcinoma, Renal Cell
2
2018
120
0.170
 Why?
DNA Polymerase II
1
2019
10
0.170
 Why?
Hodgkin Disease
1
2019
51
0.170
 Why?
DNA Mismatch Repair
1
2019
17
0.170
 Why?
Premature Birth
1
2021
154
0.170
 Why?
Dermatology
1
2020
72
0.170
 Why?
Melanoma, Experimental
1
2019
49
0.170
 Why?
Odds Ratio
3
2015
600
0.170
 Why?
Fetal Diseases
1
2019
62
0.170
 Why?
Skin Diseases
1
2020
141
0.170
 Why?
T-Lymphocytes
1
2021
374
0.170
 Why?
Sarcoma
1
2020
72
0.170
 Why?
Monocytes
1
2019
156
0.170
 Why?
Metformin
1
2020
66
0.170
 Why?
CD8-Positive T-Lymphocytes
1
2019
116
0.170
 Why?
Inflammation
2
2020
679
0.170
 Why?
Urinary Bladder Neoplasms
1
2020
173
0.170
 Why?
Methionine Adenosyltransferase
1
2018
20
0.170
 Why?
Pregnancy
7
2021
2637
0.170
 Why?
Reproducibility of Results
4
2017
1294
0.160
 Why?
Mice, Inbred C57BL
5
2024
2002
0.160
 Why?
Radiation Tolerance
1
2019
87
0.160
 Why?
DNA Helicases
1
2020
132
0.160
 Why?
Hypoglycemic Agents
1
2020
177
0.160
 Why?
Rhabdomyosarcoma
1
2018
13
0.160
 Why?
Neural Cell Adhesion Molecule L1
1
2017
2
0.160
 Why?
Nuclear Proteins
1
2020
253
0.160
 Why?
Programmed Cell Death 1 Receptor
1
2018
40
0.160
 Why?
Logistic Models
3
2015
991
0.160
 Why?
Pathology, Molecular
1
2017
24
0.160
 Why?
Proto-Oncogene Proteins p21(ras)
1
2018
70
0.160
 Why?
Hepatocytes
1
2019
214
0.150
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2017
62
0.150
 Why?
Disease Models, Animal
6
2020
1651
0.150
 Why?
Intestinal Mucosa
2
2020
259
0.150
 Why?
Tumor Necrosis Factor-alpha
2
2019
435
0.150
 Why?
Biopsy
5
2020
693
0.150
 Why?
Osteosarcoma
1
2017
37
0.150
 Why?
Pregnancy Complications
1
2021
386
0.150
 Why?
Vimentin
1
2016
33
0.140
 Why?
Neoplastic Cells, Circulating
1
2017
92
0.140
 Why?
Papillomaviridae
1
2017
107
0.140
 Why?
DNA-Binding Proteins
2
2016
462
0.140
 Why?
Oligonucleotide Array Sequence Analysis
1
2017
474
0.140
 Why?
Gene Expression Profiling
2
2019
1141
0.140
 Why?
Cadherins
1
2016
72
0.140
 Why?
Viral Load
1
2016
86
0.140
 Why?
Acetaminophen
1
2019
350
0.140
 Why?
Time Factors
3
2021
3207
0.130
 Why?
Hepatocyte Nuclear Factor 1-beta
1
2015
4
0.130
 Why?
Neoplasms, Muscle Tissue
1
2015
13
0.130
 Why?
Malate Dehydrogenase
1
2014
11
0.130
 Why?
Classification
1
2015
15
0.130
 Why?
Colposcopy
1
2015
19
0.130
 Why?
Lipogenesis
1
2014
34
0.130
 Why?
Skin Neoplasms
1
2020
532
0.130
 Why?
World Health Organization
1
2015
56
0.130
 Why?
Cytosol
1
2014
101
0.130
 Why?
Mice, Inbred BALB C
3
2021
371
0.120
 Why?
Neoplasm, Residual
1
2015
167
0.120
 Why?
Flow Cytometry
1
2017
547
0.120
 Why?
Mammary Neoplasms, Experimental
1
2015
135
0.120
 Why?
Histones
1
2016
335
0.120
 Why?
Multiple Myeloma
1
2009
3049
0.120
 Why?
High-Throughput Nucleotide Sequencing
3
2021
206
0.120
 Why?
Oncogenes
1
2013
63
0.110
 Why?
Antineoplastic Agents
2
2021
1300
0.110
 Why?
Gastrointestinal Tract
1
2014
134
0.110
 Why?
Clusterin
1
2012
6
0.110
 Why?
Patient Selection
1
2015
284
0.110
 Why?
Cell Line, Tumor
4
2020
1551
0.110
 Why?
Intestines
1
2014
204
0.110
 Why?
Membrane Proteins
1
2015
389
0.110
 Why?
Predictive Value of Tests
4
2018
1044
0.110
 Why?
Histocytochemistry
1
2012
46
0.110
 Why?
Liver
2
2019
1226
0.110
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2012
25
0.110
 Why?
Pancreatic Neoplasms
1
2015
234
0.110
 Why?
Strongyloidiasis
1
2012
9
0.110
 Why?
Risk Factors
3
2015
3934
0.110
 Why?
Cytomegalovirus Infections
1
2012
47
0.100
 Why?
Prednisone
1
2012
111
0.100
 Why?
Follow-Up Studies
2
2016
2389
0.100
 Why?
Tissue Inhibitor of Metalloproteinases
1
2011
11
0.100
 Why?
Treatment Outcome
3
2021
5609
0.100
 Why?
Teratoma
1
2011
25
0.100
 Why?
Matrix Metalloproteinases
1
2011
52
0.100
 Why?
Vascular Endothelial Growth Factor A
1
2012
233
0.100
 Why?
Adenoma, Oxyphilic
1
2010
17
0.100
 Why?
Male
9
2020
27335
0.100
 Why?
Sensitivity and Specificity
3
2020
922
0.100
 Why?
Image Processing, Computer-Assisted
1
2012
256
0.100
 Why?
Adolescent
3
2020
6896
0.090
 Why?
Phenotype
3
2019
820
0.090
 Why?
Tissue Array Analysis
3
2015
50
0.090
 Why?
Glucocorticoids
1
2012
234
0.090
 Why?
Tumor Cells, Cultured
2
2021
477
0.090
 Why?
Epigenesis, Genetic
1
2012
399
0.090
 Why?
Pregnancy Outcome
2
2021
248
0.090
 Why?
Infant, Newborn
3
2021
2923
0.080
 Why?
Pilot Projects
2
2023
805
0.080
 Why?
Telemedicine
1
2015
457
0.080
 Why?
Cell Differentiation
2
2024
720
0.080
 Why?
Hysterectomy
2
2021
89
0.080
 Why?
Cell Nucleus
2
2021
203
0.080
 Why?
Host-Pathogen Interactions
2
2021
143
0.080
 Why?
Societies, Medical
2
2019
197
0.080
 Why?
Consensus
2
2020
156
0.070
 Why?
Ventricular Pressure
1
2006
19
0.070
 Why?
Neoplasms
1
2017
1321
0.070
 Why?
Isoproterenol
1
2006
52
0.070
 Why?
Gene Expression Regulation
3
2023
1064
0.070
 Why?
Terminology as Topic
2
2018
72
0.070
 Why?
Kaplan-Meier Estimate
2
2018
514
0.070
 Why?
Serum Response Factor
1
2006
41
0.070
 Why?
Combined Modality Therapy
2
2020
693
0.070
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2016
17
0.070
 Why?
Practice Guidelines as Topic
2
2019
487
0.070
 Why?
Kidney
1
2010
821
0.070
 Why?
Neoplasm Metastasis
2
2018
252
0.060
 Why?
Cytokines
2
2020
677
0.060
 Why?
Proportional Hazards Models
2
2017
430
0.060
 Why?
Chromatography, Liquid
2
2016
243
0.060
 Why?
Cells, Cultured
2
2021
1737
0.060
 Why?
Tandem Mass Spectrometry
2
2016
248
0.060
 Why?
Th1 Cells
1
2024
50
0.060
 Why?
Heart
1
2006
361
0.060
 Why?
Dose-Response Relationship, Drug
2
2019
1476
0.060
 Why?
Interleukin-10
1
2024
106
0.060
 Why?
Gene Expression Regulation, Neoplastic
2
2018
868
0.060
 Why?
Receptors, Cytoplasmic and Nuclear
1
2023
85
0.050
 Why?
Choriocarcinoma
2
2012
7
0.050
 Why?
Genes, T-Cell Receptor
1
2021
5
0.050
 Why?
Uterine Hemorrhage
1
2021
12
0.050
 Why?
Clinical Trials, Phase I as Topic
1
2021
30
0.050
 Why?
Parturition
1
2021
53
0.050
 Why?
Phthalazines
1
2021
19
0.050
 Why?
Remission Induction
1
2021
222
0.050
 Why?
Quinazolines
1
2021
39
0.050
 Why?
Vulva
1
2020
18
0.050
 Why?
Research Report
1
2020
15
0.050
 Why?
Taurine
1
2020
16
0.050
 Why?
Lymphocyte Activation
1
2021
197
0.050
 Why?
Herb-Drug Interactions
1
2020
30
0.050
 Why?
Metabolic Networks and Pathways
1
2021
104
0.050
 Why?
Mucin-2
1
2020
9
0.050
 Why?
Toxicity Tests
1
2020
52
0.050
 Why?
Alkaline Phosphatase
1
2020
99
0.050
 Why?
Molecular Targeted Therapy
1
2021
128
0.050
 Why?
Risk
1
2021
343
0.050
 Why?
Piperazines
1
2021
115
0.050
 Why?
Chorionic Villi
1
2019
3
0.050
 Why?
Chemokines
1
2020
96
0.050
 Why?
Birth Weight
1
2020
126
0.050
 Why?
Kruppel-Like Transcription Factors
1
2020
40
0.040
 Why?
Preoperative Period
1
2020
59
0.040
 Why?
Receptors, Progesterone
1
2020
57
0.040
 Why?
Endothelium
1
2019
45
0.040
 Why?
Ultrasonography, Doppler, Color
1
2019
38
0.040
 Why?
Pyrimidines
1
2021
196
0.040
 Why?
Intercellular Adhesion Molecule-1
1
2019
75
0.040
 Why?
Colon
1
2020
111
0.040
 Why?
United States
3
2016
5204
0.040
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2014
674
0.040
 Why?
Chest Pain
1
2019
66
0.040
 Why?
Glutamine
1
2020
168
0.040
 Why?
Cytochrome P-450 Enzyme System
1
2020
192
0.040
 Why?
Dyspnea
1
2019
78
0.040
 Why?
Liver Function Tests
1
2019
43
0.040
 Why?
Estrogen Receptor alpha
1
2020
95
0.040
 Why?
Mice, Transgenic
2
2014
658
0.040
 Why?
Fatal Outcome
1
2019
225
0.040
 Why?
Mice, Inbred Strains
1
2019
199
0.040
 Why?
Drug Synergism
1
2019
171
0.040
 Why?
Gestational Age
1
2020
435
0.040
 Why?
Imaging, Three-Dimensional
1
2019
172
0.040
 Why?
Xenograft Model Antitumor Assays
1
2019
219
0.040
 Why?
Mice, Nude
1
2019
284
0.040
 Why?
Wolffian Ducts
1
2018
1
0.040
 Why?
Mullerian Ducts
1
2018
4
0.040
 Why?
Nephrectomy
1
2018
92
0.040
 Why?
Mutation Rate
1
2018
40
0.040
 Why?
Lymph Node Excision
1
2019
140
0.040
 Why?
Cell Lineage
1
2018
93
0.040
 Why?
Mixed Tumor, Mullerian
1
2017
3
0.040
 Why?
Ultrasonography, Prenatal
1
2019
187
0.040
 Why?
DNA Copy Number Variations
1
2018
114
0.040
 Why?
Anal Canal
1
2017
24
0.040
 Why?
Skin
1
2020
468
0.040
 Why?
Matrix Attachment Region Binding Proteins
1
2017
31
0.040
 Why?
Dietary Supplements
1
2020
452
0.040
 Why?
Telomerase
1
2016
30
0.040
 Why?
Disease-Free Survival
1
2017
488
0.040
 Why?
Macrophages
1
2019
404
0.040
 Why?
Transcriptome
1
2019
346
0.040
 Why?
Lymph Nodes
1
2019
284
0.040
 Why?
Vaccines, Subunit
1
2016
20
0.040
 Why?
Ontario
1
2016
50
0.040
 Why?
Mesonephros
1
2016
1
0.040
 Why?
Diet
1
2020
584
0.030
 Why?
T-Lymphocytes, Regulatory
1
2016
85
0.030
 Why?
Antiporters
1
2015
19
0.030
 Why?
Extracellular Fluid
1
2015
19
0.030
 Why?
Anion Exchange Protein 1, Erythrocyte
1
2015
15
0.030
 Why?
Signal Transduction
1
2023
1751
0.030
 Why?
Leukocytes, Mononuclear
1
2016
133
0.030
 Why?
S100 Proteins
1
2015
41
0.030
 Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2015
79
0.030
 Why?
Cell Hypoxia
1
2015
87
0.030
 Why?
Pressure
1
2015
120
0.030
 Why?
Cell Count
1
2015
181
0.030
 Why?
Blood Vessels
1
2015
78
0.030
 Why?
Receptor Protein-Tyrosine Kinases
1
2015
52
0.030
 Why?
Drug Evaluation, Preclinical
1
2015
158
0.030
 Why?
Random Allocation
1
2015
308
0.030
 Why?
Radiotherapy Dosage
1
2015
245
0.030
 Why?
Immunoenzyme Techniques
1
2014
166
0.030
 Why?
Genetic Predisposition to Disease
1
2018
571
0.030
 Why?
Proteome
1
2016
178
0.030
 Why?
Prospective Studies
1
2020
2604
0.030
 Why?
Likelihood Functions
1
2014
61
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2014
206
0.030
 Why?
In Situ Hybridization, Fluorescence
1
2015
278
0.030
 Why?
Vaccination
1
2016
298
0.030
 Why?
Genes, erbB-1
1
2013
9
0.030
 Why?
Multivariate Analysis
1
2015
643
0.030
 Why?
Apoptosis
1
2020
1302
0.030
 Why?
Gene Frequency
1
2013
120
0.030
 Why?
Lipid Metabolism
1
2014
194
0.030
 Why?
Anti-Bacterial Agents
1
2019
825
0.030
 Why?
SEER Program
1
2013
95
0.030
 Why?
Adiposity
1
2014
142
0.030
 Why?
Mesentery
1
2012
36
0.030
 Why?
Communication
1
2015
265
0.030
 Why?
Rural Health Services
1
2015
175
0.030
 Why?
Diet, High-Fat
1
2014
216
0.030
 Why?
Research Design
1
2015
356
0.030
 Why?
Phosphatidylinositol 3-Kinases
1
2013
153
0.030
 Why?
Vascular Endothelial Growth Factor Receptor-3
1
2012
5
0.030
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
7
0.030
 Why?
Pregnancy Proteins
1
2012
8
0.030
 Why?
Angiopoietin-2
1
2012
16
0.030
 Why?
Angiopoietin-1
1
2012
18
0.030
 Why?
Ovary
1
2012
105
0.030
 Why?
Ivermectin
1
2012
8
0.030
 Why?
Neoplasms, Glandular and Epithelial
1
2012
48
0.030
 Why?
Antiparasitic Agents
1
2012
9
0.030
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
37
0.030
 Why?
Socioeconomic Factors
1
2015
638
0.030
 Why?
Insulin Resistance
1
2014
299
0.030
 Why?
Hydatidiform Mole
1
2011
2
0.030
 Why?
Infant
1
2020
3832
0.030
 Why?
Algorithms
1
2015
697
0.020
 Why?
Crohn Disease
1
2012
97
0.020
 Why?
RNA, Messenger
1
2014
1203
0.020
 Why?
Isoenzymes
1
2011
176
0.020
 Why?
Interleukin-6
1
2012
315
0.020
 Why?
Necrosis
1
2010
208
0.020
 Why?
Promoter Regions, Genetic
1
2012
520
0.020
 Why?
Gene Expression
1
2012
664
0.020
 Why?
Radiography
1
2011
526
0.020
 Why?
Risk Assessment
1
2015
1361
0.020
 Why?
Cell Line
1
2012
1152
0.020
 Why?
Cohort Studies
1
2013
1547
0.020
 Why?
DNA Methylation
1
2012
575
0.020
 Why?
Rats
1
2014
3417
0.020
 Why?
Blotting, Western
1
2006
684
0.020
 Why?
Myocardium
1
2006
443
0.010
 Why?
Age Factors
1
2006
1200
0.010
 Why?
Child
1
2011
7372
0.010
 Why?
Quick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (394) concept(s)
_
Co-Authors Expand Description
See all (52) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department